Role of Toll-Like Receptor-4 in Lung Ischemia-Reperfusion Injury

Slides:



Advertisements
Similar presentations
Mary E. Huerter, MD, MA, Ashish K
Advertisements

Hypercholesterolemia Impairs the Myocardial Angiogenic Response in a Swine Model of Chronic Ischemia: Role of Endostatin and Oxidative Stress  Munir Boodhwani,
A Scimitar Syndrome Variant: Anomalous Systemic Arterial Supply to the Right Lung With Normal Pulmonary Venous Return  Luis Gorospe, MD, Amparo Esteban-Peris,
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
Michael Kalina, DO, Frederick Giberson, MD 
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Salah Sabbagh, MD, Michele M. Henry Salzman, BS, Robert A
Keiji Ohata, MD, Toyofumi F
Functional Roles of Tumor Necrosis Factor-Alpha and Interleukin 1-Beta in Hypoxia and Reoxygenation  Heather E. Merry, MD, Patrick Phelan, MD, Matthew.
Patrick S. Wolf, MD, Heather E. Merry, MD, Alexander S
Trevor Williams, MD, MPH, Brian C
Baiya Krishnadasan, MD, Babu V
Patrick Phelan, MD, Heather E
Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia  John Cha, MD, Zhiping Wang, MD, Lihua Ao, BS, Ning.
Application of the Human Factors Analysis and Classification System Methodology to the Cardiovascular Surgery Operating Room  Andrew W. ElBardissi, BS,
Invited Commentary The Annals of Thoracic Surgery
The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report  John S. Ikonomidis, MD, PhD  The Annals of Thoracic.
Burdens Without Blessings: Peer Reviewers Get No Respect
Ho Young Hwang, MD, Jun Sung Kim, MD, Ki-Bong Kim, MD, PhD 
Right Gastroepiploic Artery Graft for Myocardial Revascularization: Prevalence of Atherosclerosis and Availability as a Conduit  Kwang Ree Cho, MD, PhD,
Sivelestat Attenuates Lung Injury in Surgery for Congenital Heart Disease With Pulmonary Hypertension  Norikazu Nomura, MD, PhD, Miki Asano, MD, PhD,
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury
Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R
Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Interleukin-6 Regulation of Direct Lung Ischemia Reperfusion Injury
Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury  William E. Stansfield,
Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD 
Pleural Metastasis of Osteosarcoma
Trevor Williams, MD, MPH, Brian C
Who Do You Say You Are? The Annals of Thoracic Surgery
Protection by 20-5,14-HEDGE Against Surgically Induced Ischemia Reperfusion Lung Injury in Rats  Irshad Ali, PhD, Stephanie Gruenloh, BS, Ying Gao, MS,
Use of Amiodarone After Major Lung Resection
Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma
Primary De Novo Angiosarcoma of the Pleura
Abel Gómez-Caro, MD, Pedro Arguis, MD  The Annals of Thoracic Surgery 
Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD 
Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy  Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.
Gerald G.R. Sng, Cameron D. Wright, MD  The Annals of Thoracic Surgery 
Validating the use of short interfering RNA as a novel technique for cell-specific target gene knockdown in lung ischemia–reperfusion injury  Heather.
Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty
Editorial Board, January 2010
Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD 
Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation 
William M. Whited, MD, Paul Henley, BS, Erin M
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Daniel P. Mulloy, MD, Ashish K. Sharma, MBBS, PhD, Lucas G
Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience  Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.
Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve  Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD 
Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation  Scott D Ross, MD, Curtis G Tribble, MD, John R Gaughen,
Patrick O. Myers, MD  The Annals of Thoracic Surgery 
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Invited Commentary The Annals of Thoracic Surgery
Robert Lee Replogle, September 30, 1931–May 9, 2016
Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.
Pulmonary Embolectomy for Acute Massive Pulmonary Embolism
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Endothelial Cell Injury in Cardiovascular Surgery
Mark I. Block, MD  The Annals of Thoracic Surgery 
Late Consequences of a Much Earlier Decision
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Nervous Network of Skeletonized Internal Thoracic Artery
Harvey Edward Garrett, MD, Bradley A. Wolf, MD 
Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M
Presentation transcript:

Role of Toll-Like Receptor-4 in Lung Ischemia-Reperfusion Injury Heather E. Merry, MD, Patrick Phelan, MD, Mathew R. Doak, BS, Minqing Zhao, MD, PhD, Billanna Hwang, MPH, Michael S. Mulligan, MD  The Annals of Thoracic Surgery  Volume 99, Issue 4, Pages 1193-1199 (April 2015) DOI: 10.1016/j.athoracsur.2014.12.062 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Sequence-specific toll-like receptor (TLR)-4 knockdown with TLR-4 short interference (si)RNA. Pretreatment with TLR-4 siRNA prior to the ischemia and reperfusion (IR) protocol resulted in a 69% (p < 0.01) and 92% (p < 0.001) decrease in TLR4 concentration on western blot for sequences 1 and 2, respectively, when compared with animals receiving control non-coding siRNA. The Annals of Thoracic Surgery 2015 99, 1193-1199DOI: (10.1016/j.athoracsur.2014.12.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Cell-specific toll-like receptor (TLR)-4 knockdown with TLR-4 short interference (si)RNA. Alveolar macrophages (AM) isolated from lungs treated with TLR-4 siRNA resulted in a 93% reduction (p < 0.001) in TLR-4 levels on western blot when compared with lungs treated with non-coding siRNA. No significant reduction in TLR-4 levels was found in pulmonary artery endothelial cells (PAEC), type 2 pneumocytes (T2P), or circulating white blood cells (WBC) isolated from animals treated with TLR-4 siRNA compared with those treated with non-coding siRNA. The Annals of Thoracic Surgery 2015 99, 1193-1199DOI: (10.1016/j.athoracsur.2014.12.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Reduction on stress-activated protein kinase activation with toll-like receptor (TLR)-4 knockdown in lung ischemia-reperfusion injury. Although there is no difference between total levels of c-Jun-terminal kinase (JNK) and p38 after the ischemia and reperfusion (IR) protocol when comparing control and toll-like receptor (TLR)-4 short interference (si)RNA, the levels of phosphorylated JNK and p38 are significantly decreased (p < 0.01) for animals that were pretreated with TLR-4 siRNA compared with controls. The Annals of Thoracic Surgery 2015 99, 1193-1199DOI: (10.1016/j.athoracsur.2014.12.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 The toll-like receptor (TLR)-4 knockdown reduced permeability index in lung ischemia-reperfusion injury. The ischemia and reperfusion (IR) protocol increases vascular permeability ninefold in control animals pretreated with no short interference (si)RNA, TLR-4 siRNA prior to the IR protocol results in vascular permeability 90% less than positive controls (p < 0.001). This is equivalent to control animals that did not undergo the IR protocol. The Annals of Thoracic Surgery 2015 99, 1193-1199DOI: (10.1016/j.athoracsur.2014.12.062) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions